Physician profile
Megan E Keyser
NPI 1144732843
$777.64
in general payments reported to CMS, 2019-2025
12 companies · $221 in 2025
The $221 reported for 2025 was more than what 90% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $30.53 · 2022: $120 · 2023: $160 · 2024: $246 · 2025: $221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $627.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $626.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $182.25 | 2023-2025 | Xifaxan |
| Abbvie INC. | $122.03 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $93.41 | 2021-2025 | Bridion |
| Pacira Pharmaceuticals Incorporated | $78.58 | 2022-2024 | Exparel |
| Regeneron Healthcare Solutions, INC. | $67.37 | 2022-2025 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $59.48 | 2023-2024 | Entyvio |
| Janssen Biotech, INC. | $52.34 | 2024-2025 | Stelara, Tremfya |
| Madrigal Pharmaceuticals | $45.60 | 2024-2025 | Rezdiffra, Resmetirom |
| Heron Therapeutics, INC. | $23.05 | 2024 | Aponvie |
| Vyaire Medical, INC. | $22.17 | 2022 | |
| Hologic Sales and Service, LLC | $16.76 | 2023 | Coolseal Generator |
| Intercept Pharmaceuticals, INC. | $14.60 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Keyser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.